5.2: In adult kidney transplant recipients, choose a BP- lowering agent after taking into account the time after transplantation, use of calcineurin inhibitors, presence or absence of persistent albuminuria, and other co-morbid conditions. (Not Graded) RATIONALE BP-lowering agents are prescribed in 70 to 90% of kidney transplant recipients, according to both registry reports and There are many considerations in choosing anti- hypertensive drugs for use in adult kidney transplant recipients. These include side effects that are also seen in the general population, side effects particular to kidney transplant patients (e.g.